Sort
23,748 grants matching “melanoma”
University of New Mexico Cancer Center Support
$278,627Cheryl L Willman · University Of New Mexico · P30 · FY2009 · CA
Immunological Modulation of Ocular Tumor Metastases
$278,621Jerry Niederkorn · Ut Southwestern Medical Center · R01 · FY2011 · CA
T Cell Trafficking in Adoptive Cellular Immunotherapy
$278,596University Of Michigan At Ann Arbor · R01 · FY2005 · CA
T Cell Trafficking in Adoptive Cellular Immunotherapy
$278,596University Of Michigan At Ann Arbor · R01 · FY2003 · CA
T Cell Trafficking in Adoptive Cellular Immunotherapy
$278,596University Of Michigan At Ann Arbor · R01 · FY2004 · CA
Novel Single, Dual and Multitargeted Inhibitors of RTKs
$278,580Aleem Gangjee · Duquesne University · R01 · FY2007 · CA
Preclinical Therapeutics
$278,555Frank Patrick McCormick · University Of California, San Francisco · P30 · FY2015 · CA
Core 1: Biospecimen and Translational Pathology Core
$278,515Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
Mechanisms of PDT in Patients
$278,429Nathalie Zeitouni · Roswell Park Cancer Institute Corp · P01 · FY2013 · CA
Enantioselective Functionalizations of Azomethines and Alkenes
$278,399Jeffrey Nicholas Johnston · Vanderbilt University · R01 · FY2014 · GM
Role of IKK in NSCLC: Modulation of SMRT and NF-kappaB
$278,392Marty W Mayo · University Of Virginia · R01 · FY2009 · CA
Role of IKK in NSCLC: Modulation of SMRT and NF-kappaB
$278,392Marty W Mayo · University Of Virginia · R01 · FY2010 · CA
The role of Mc1r in melanocytic UV-induced DNA damage and repair responses
$278,391John A Dorazio · University Of Kentucky · R01 · FY2013 · CA
LOSS OF DIFFERENTIATION IN CONTROL IN MELANOMA
$278,346Institute For Cancer Prevention · R01 · FY2000 · CA
Molecular Mechanisms of Metastasis Suppression by NM23
$278,196David M Kaetzel · University Of Kentucky · R01 · FY2009 · CA
Eastern Cooperative Oncology Group
$278,182Patrick J Loehrer · Indiana University Indianapolis · U10 · FY2008 · CA
Regulation of Cytokine Gene Expression by mRNA Turnover
$278,123Sidney Pestka · Univ Of Med/Dent Nj-R W Johnson Med Sch · P01 · FY2007 · AI
Dendritic Cell Strategies to Tumor Reactive T Cells
$278,046University Of Pittsburgh At Pittsburgh · R01 · FY2003 · CA
Enantioselective Functionalizations of Azomethines and Alkenes
$278,001Jeffrey Nicholas Johnston · Vanderbilt University · R01 · FY2015 · GM
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
$277,899James R. Heath · California Institute Of Technology · U54 · FY2017 · CA
Immunization Against Melanoma Differentiation Antigens
$277,892Alan N. Houghton · Sloan-Kettering Inst Can Research · R01 · FY2006 · CA
Sensitive detection of malignancy in primary acquired melanosis by advanced optical imaging
$277,819Ji Yi · Boston Medical Center · R21 · FY2018 · EY
Novel RNA Markers for Detecting Colon Cancer Metastasis
$277,748Sylvie Lucie Beaudenon · Ambion Diagnostics, Inc. · R43 · FY2008 · CA
Investigating PROTAC-mediated antigen degradation as a novel strategy to enhance cytotoxic T-cell responses against cancer in vivo.
$277,686Christopher Schliehe · Erasmus Medical Center · R21 · FY2022 · CA
Regulation of Cytokine Gene Expression by mRNA Turnover
$277,685Sidney Pestka · Univ Of Med/Dent Nj-R W Johnson Med Sch · P01 · FY2008 · AI